Ferentino is a 14,034 m2 (151,061 ft2) facility specializing in integrated sterile liquid and lyophilized product development and commercial manufacturing, including high potency products and LVP.
Specialized Capabilities
- Sterile Liquid vials (SVP & LVP)
- Biopharmaceuticals, including:
- Monoclonal antibodies
- Other recombinant proteins
- Monoclonal antibodies
- Proteins
- Peptides
- Sterile Lyophilized vials
- Secondary packaging (vials)
- Small molecules
- Scale up
- Blood product
High-Potency Capabilities
Our Ferentino Facility has high-potency capabilities up to category 3b for commercial and development projects, and has received regulatory approval from:
- AIFA (Agenzia Italiana del Farmaco)
- FDA (Food and Drug Administration)
- ANVISA (Brazilian Ministry of Health)
- MFDS (Ministry of Food and Drug Safety Korea)
- Turkey MoH
- Health Canada
- Japan PMDA (Pharm. and Med. Dev. Agency)
- TFDA (Taiwan Food and Drug Administration)
- Russian Certificate of Center
Learn more about the specific equipment and capabilities at this site.